James H. Stanker - 05 Aug 2022 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Chief Financial Officer
Signature
/s/ James H. Stanker by Michael B. Kirwan, as Attorney-in-Fact
Issuer symbol
PCSA
Transactions as of
05 Aug 2022
Net transactions value
-$7,805
Form type
4
Filing time
09 Aug 2022, 16:28:04 UTC
Previous filing
05 Jul 2022
Next filing
05 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCSA Common Stock Options Exercise +7,601 +17% 51,712 05 Aug 2022 Direct F1
transaction PCSA Common Stock Tax liability $7,805 -2,462 -4.8% $3.17 49,250 05 Aug 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vesting of time-based restricted shares.